-TUNKENSTEIN, Greenblatt, and Solomon in 1948 reported on certain physiological changes which followed electroshock treatment. 2 Since that time, several papers have appeared which have attempted to define the physiological meaning and the prognostic value of blood-pressure curves as they are affected by intravenous neo-epinephrine and intramuscular Mecholyl (methacholine).
Funkenstein and his co-workers have also suggested modification of present diagnostic categories on the basis of response to the test. They have reported that abstraction disturbances occur in statistically meaningful fashion in certain of the response groups, 8 and they plan more study of the psychological accompaniments in various of the test groups.
As a logical development proceeding from this work, Ernest Gellhorn has attempted to clarify the phenomena reported from the neurophysiological aspect, while a study by L. Alexander has reported use of the Funkenstein test as a valuable clinical guide in the choice of modes of treatment in private practice.
The present study was designed to evaluate the Funkenstein test in terms of prognostic value quite apart from the use of electroshock treatment. Reports have shown that a high percentage of patients with a high basal blood pressure who respond to Mecholyl with a marked and prolonged hypotensive effect improve with electroshock treatment. 1 VOL. XVIII, NO. 2, 1956 is in contrast to the poor electroshock results in patients with a hypertensive response or a minimal response to Mecholyl.
It was believed that a study in a case series could reveal whether certain responses to Mecholyl constituted a physiological reflection of clinical signs which of themselves are considered of prognostic significance for successful outcome.
We will report the result of observations in a group of 68 patients admitted to the New York State Psychiatric Institute on a voluntary basis, the principal mode of treatment having been psychotherapy. Efforts will be made to evaluate what has been said as to the physiological meaning of the test to date, and to assess the test's present clinical value.
Procedure
Initially, the test procedure as reported by Funkenstein et al* was administered routinely to all cases at the time of their admission by members of the resident staff, under the direction of one of the authors (R.C.). In the beginning of the study, tests were also administered to patients who had been under active treatment (psychotherapy) for several months prior to testing. The Funkenstein procedure was used without modification, as follows: 4 After the patient had been lying down in quiet surroundings for at least thirty minutes, two hours after the last meal, the systolic blood pressure was taken.
Epinephrine HC1, 0.025 mg. in normal saline solution, was injected intravenously and the systolic blood pressure readings were taken until the systolic blood pressure returned to the pre-according to the criteria established and deinjection level.
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6 0 . Following the administration of each drug, the patient was questioned specifically about subjective sensations, especially anxiety in relation to the drug injected and, if so, whether or not it was similar to patient's spontaneous anxiety attacks.
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Measures
Following the performance of the physiological tests as described, graphs were constructed from the data and sorted into groups turn to the preinjection level during the twentyfive-minute observation period (Fig. 1) .
GROUP II-III. Epinephrine: Rise in systolic blood pressure in excess of 50 mm. Hg. Mecholyl: Moderate or slight fall in systolic blood pressure with or without slight rise above preinjection level but with establishment of homeostasis, i.e., return to preinjection level of blood pressure and maintenance of it, within the twenty-five-minute observation period (Fig. 1) .
GROUP IV. Epincphrine: Rise in systolic blood pressure in excess of 50 mm. Hg. Mecholyl:
Moderate fall in systolic blood pressure with marked compensatory delayed rise before establishment of homeostasis (return to preinjection level and maintenance of it for three to five minutes within the twenty-five-minute observation period (Fig. i ) .
GROUP V. Epinephrine: Rise in systolic blood pressure of 50 mm. Hg or less. Mecholyl: Fall in systolic blood pressure with failure to reach the preinjection blood pressure level within the twenty-five-minute observation period (Fig. 1) .
GROUP VI. Epinephrine: Rise in systolic blood pressure in excess of 50 mm. Hg. Mecholyl: Fall in systolic blood pressure with failure to reach preinjection blood pressure level within twenty-five-minute observation period ( Fig. 1) .
GROUP VII. In this group are included all cases in which a chill occurred after Mecholyl. A reliable blood pressure curve could not be established owing to noise engendered by the muscular contractures during the chill (Fig. 1 ).
In the first 46 cases, both the intravenous epinephrine and the intramuscular Mecholyl were administered as outlined by Funkenstein et al. In subsequent cases, only the Mecholyl was administered since this seemed, on review, to be the only significant and meaningful portion of the test. This is discussed in more detail below.
Findings
In evaluating the method of presentation in this small series of 68 cases, it was felt advisable to avoid diagnostic classification, since it has been demonstrated 4 that the test cuts across diagnostic lines. For purposes of clarity it is sufficient to say that in our case series the patients' disturbances were of sufficient dimension to warrant hospitalization, and that in all cases intactness was such that the patient was legally competent and had admitted himself voluntarily to the hospital.
The findings reported in this series relate to the adequacy of affect per group and to the degree of clinical improvement.
Appraisal of Affect
Although independent estimates of the adequacy of affect were made by at least two psychiatrists after the clinical data in each case had been carefully assessed, it cannot be VOL. XVIII, NO. 2, 1956 145 too strongly emphasized that the results as reported are subjective in essence. They refer to an appraisal by relatively experienced observers of the adequacy or inadequacy of emotional response to seemingly meaningful material, as it appears in the course of the interpersonal exchange which constitutes the psychotherapeutic interview. Such estimation of adequacy takes into consideration, among other things, the amount of affect shown, its appropriateness and relevance to the verbal productions of the patient, and whether it is maintained to the point of perseverance or so short-lived as to appear labile and uncontrolled.
These criteria were used to place patients into two groups: those whose affect was con- Table 1 is a frequency chart showing the affect estimates of the various groups where adequacy of affect is compared to the kind of blood-pressure response to Mecholyl. Groups I and IV are placed together in arriving at a percentage score of adequate affect, since in these groups there is a pronounced hypertensive response to Mecholyl varying only in the time sequence and degree in which the hypertensive response occurs. Groups II and III are considered together since this response is essentially different from all other groups in the relatively constant blood-pressure measure- 
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provement at the time of discharge and does not state anything of the subsequent course. It is obvious that extensive follow-up studies are required before the prognostic value of the test can be assayed. Table 2 with Table 1 indicates some trend towards positive correlation between degree of hypotensive response to Mecholyl and initial favorable clinical outcome. We must stress, however, that these findings are not advanced as reliable indicators in long-term prognosis.
Affect and Favorable Outcome
In Table 3 , which correlates the clinical outcome with affect appraisal without respect to the Funkenstein groups, we find that 74 per cent of those with adequate affect improved. This is in harmony with the 80 per cent of Group V-VI cases with adequate affect in Table 1 and the 78 per cent improvement rate for this group in Table 2 .
It is important to note that in Group I-IV patients who were discharged as improved, of 10 cases of adequate affect, 9 improved. In the 11 Group I-IV patients with inadequate affect, only 1 was discharged as improved. This finding is unique for the Group I-IV cases. In Group II-III, of 12 patients with inadequate affect, 6 improved, while in the 14 Group V-VI cases there were only 2 patients noted to have inadequate affect. Of these 2, 1 was discharged as improved. ments throughout the test period without predominance of either hypertensive or hypotensive response. Groups V and VI, which are differentiable only on the basis of response to injected epinephrine, are considered together. There were no Group VII cases in our series.
It will be observed from Table 1 that those patients whose affect tends toward the adequate and appropriate show a more definite hypotensive response to Mecholyl (Group V-VI). Patients who show disturbance in the adequacy of their affect tend to fall into Group I-IV (hypertensive response), and to a lesser extent into Group II-III. There is a trend which suggests some correlation between clinically estimated affect and degree of hypotensive response to Mecholyl.
Response to Mecholyl and Outcome
An attempt was further made to determine whether there was some correlation between the type of response to Mecholyl and the therapeutic outcome. Patients were divided into two groups-those discharged as improved and those discharged showing minimal or no improvement.
Criteria for "Improvement"
Our criteria for improvement differed considerably from Funkenstein's. He rated as improved "any patient who in one month after organotherapy was sufficiently recovered so that he could be discharged from the hospital, and remain out of the hospital for at least one month." 4 The patient whom we rate as improved still retains some clinical evidence of personality conflict but is well enough so that our expectation on discharge is that the patient will make an adequate socioeconomic adjustment for an indeterminate period. Still, our estimate notes onlv the patient's clinical im- 
Discussion
Response to Epinephrine
As indicated above, the epinephrine portion of the test as described by Funkenstein et al. was administered only to the first 46 patients in our series. It was thereafter omitted as part of the routine procedure because it failed to give any meaningful information. The response to epinephrine has been used as a predictor of response to electroshock therapy, but only 2 of our cases were selected for this form of treatment and the test was consequently of little value to us in this regard. Anxiety following injection of epinephrine and/or failure of the blood pressure to rise more than 50 mg. Hg following the epinephrine injection have been used as indicators that response to electroshock therapy will be poor, but our series could not confirm the usefulness of these responses in this regard. Of the patients who did receive the epinephrine injection, 12 showed the anxiety reaction and 7 showed the minimal blood-pressure reaction. All these cases were quite evenly distributed throughout the Funkenstein groups, and their clinical affect and therapeutic outcome varied to the same degree that was seen with the patients who did not show such idiosyncratic responses to epinephrine injection. We did not find, in other words, that any reliable conclusions could be drawn on the basis of either or both of these responses to intravenous epinephrine.
Pharmacodynamics
It is further believed that the pharmacodynamics of epinephrine are too poorly understood at this time to allow of valid inferences regarding the physiological meaning of responses to the drug. As administered in this test, by intravenous injection, epinephrine may stimulate portions of the sympathetic nervous system or it may not; but if it does, it is still unclear as to whether the receptor organs, the sympathetic ganglia, and the hypothalamic centers have been stimulated singly or collectively. It was considerations such as these which led to our abandonment of this part of the test.
Response to Mecholyl
Responses to intramuscularly administered Mecholyl, on the other hand, did appear to be meaningful, particularly as they were correlated with adequacy of affect and therapeutic outcome. Table 1 , for instance, shows that there is a positive correlation between the hypotensive reaction to Mecholyl (Groups V-VI) and the adequacy of affect. Affect was adjudged adequate in 80 per cent of cases in Groups V-VI, but only in 48 per cent of cases in Groups I-IV.
Association with Favorable Outcome
The hypotensive response to Mecholyl is furthermore associated with an initially favorable clinical outcome. Table 2 shows that 78 per cent of cases in Groups V-VI showed improvement, but only 48 per cent in Groups I-IV. This is essentially confirmatory of Funkenstein's findings 4 regarding initial prognostic value of the test, but it should again be noted that the frequency of our use of electroshock therapy and our criteria for improvement differ from his, as outlined in our section on the findings. And we must underline that our data are not advanced as indicating any value in the test for long-range
•prognosis. Table 3 shows that adequate affect was associated with a favorable therapeutic outcome in our patients. This positive correlation between adequacy of affect and clinical improvement was particularly marked in Groups I-IV, where 90 per cent of cases with adequate affect showed improvement. From these correlations we infer that the Mecholyl response may to some degree be seen as a measure of the physiological substrata of adequate affect. Certainly much more intense investigation in this particular area would seem warranted.
Interpretations of Reactions to Mecholyl
There is another large area of inquiry which is pointed to by the conflicting theories of the mechanism of the Mecholyl response in the Funkenstein test. Interpretations of the different types of reaction to intramuscular Mecholyl are not easy to make. As Holier so appropriately points out, the common tendency to emphasize the sympathetic nervous system at the expense of the parasympathetic, or vice versa, obscures the fact that the two are synergistic rather than antagonistic. A hasty review of these interdependent systems at this time might serve to explain the existence of such differing theoretical explanations of the Mecholyl response. Acetylcholine is the chemical mediator of the parasympathetic nervous system, but by reason of its nicotinic activity it controls the sympathetic ganglia (including the adrenal medulla) and thus stimulates the production of arterenol (norepinephrine) and epinephrine. Similarly, epinephrine will stimulate the parasympathetic system to activity which tends to restore the previous balance between the two portions of the autonomic system.
Theoretical Explanations
Funkenstein et al. posit that the hypotensive response to Mecholyl (Group V-VI) is caused by an excessive secretion of an epinephrinelike substance, while the small response of Group II-III is due to the excessive secretion of a norepinephrine-like substance.
3 ' 4 The Group I response is interpreted as a release from the influence of the sympathetic system. The authors have advanced experimental findings in support of this theory. 5 Another interpretation of the same data is offered by Gellhom, who attributes the Group V-VI (hypotensive) response to depression of the hypothalamic sympathetic center and the hypertensive response to hyperactivity of this center. 6 He thus considers the Mecholyl portion of the test as a measure of the degree of hypothalamic excitability. Hoffer, on the other hand, contends that Mecholyl has only weak nicotinic activity and so has little direct effect on the sympathetic ganglia and the production of epinephrine. He thereby discounts Mecholyl as any measure of autonomic nervous system reactivity, 7 and suggests that atropine would give more valid results.
Meanwhile, all the theories forwarded to date have failed to take account of the carefully described experiments of Perera et al.
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They reported a hypotensive response to injected Mecholyl in both Addison's disease and rheumatoid arthritis. These findings point up the need for further investigation of several areas, including the role of the adrenal cortex in neurophysiology and for more complete definition of the possible interrelationships between adrenal cortical function and neurophysiological responses. It is felt that any theoretical formulation which does not take into account all factors is misleading and serves only to emphasize the need for further experimentation in the area of the pharmacology of emotion. In the light of our present knowledge this area of investigation cannot be restricted to any single system of the total organism.
Summary
1. The Funkenstein adrenalin-Mecholyl test was administered to 46 hospitalized psychiatric patients. In 22 subsequent cases, only the Mecholyl was administered, since in our series this seemed the only meaningful portion of the test.
2. The Funkenstein test groups were correlated with clinical estimates of adequacy of affect and it was found that the groups with a hypotensive response to Mecholyl (Groups V-VI) had a significantly higher percentage (80 per cent) of adequate and appropriate affect than the hypertensive groups (Groups I-IV), only 48 per cent of which had adequate affect.
3. The Funkenstein test groups were also correlated with clinical outcome in our series, where the principal mode of treatment was psychotherapy; it was found that the hypotensive response groups (Groups V-VI) had a significantly higher improvement rate (78 per cent) than the hypertensive groups (48 per cent).
4. Finally, clinical outcome was correlated with clinically estimated affect without respect to the Funkenstein groups, and here it was found that improvement rate in patients with adequate affect was 74 per cent, whereas only 32 per cent of patients with inadequate affect showed improvement.
5. The positive correlation between adequacy of affect and clinical improvement was particularly marked in Groups I-IV, where 90 per cent of cases with adequate affect im-proved, whereas only 9 per cent of cases with inadequate affect showed improvement.
6. None of these findings is advanced as reliable indicators in long-term prognosis until outcome of follow-up studies can be assayed.
7. The psychophysiological significance and several conflicting explanations of the Mecholyl responses are discussed.
